UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis

Journal of oncology pharmacy practice, 2019-09, Vol.25 (6), p.1301-1304

2019

Volltextzugriff (PDF)

Defining cytotoxic drugs – you know it when you see it?

Journal of oncology pharmacy practice, 2021-12, Vol.27 (8), p.1958-1962

2021

Volltextzugriff (PDF)

Efficacy of nivolumab four-weekly dosing schedule based on body weight

Journal of oncology pharmacy practice, 2019-06, Vol.25 (4), p.961-963

2019

Volltextzugriff (PDF)

Approach to initiating QT-prolonging oncology drugs in the ambulatory setting

Journal of oncology pharmacy practice, 2019-01, Vol.25 (1), p.198-204

2019

Volltextzugriff (PDF)

Clinical considerations of hyaluronidase as an adjunct to subcutaneous rituximab injection

Journal of oncology pharmacy practice, 2019-06, Vol.25 (4), p.964-965

2019

Volltextzugriff (PDF)

Loperamide and cardiac events: Is high-dose use still safe for chemotherapy-induced diarrhea?

Journal of oncology pharmacy practice, 2018-12, Vol.24 (8), p.634-636

2018

Volltextzugriff (PDF)

Safe handling of monoclonal antibodies: Too large to be hazardous?

Journal of oncology pharmacy practice, 2018-04, Vol.24 (3), p.218-220

2018

Volltextzugriff (PDF)

Survival outcomes associated with different sunitinib dosing regimens in metastatic renal cell carcinoma

Journal of oncology pharmacy practice, 2020-01, Vol.26 (1), p.67-73

2020

Volltextzugriff (PDF)

A deliberative framework to identify the need for real-life evidence building of new cancer drugs after interim funding decision

Journal of oncology pharmacy practice, 2018-12, Vol.24 (8), p.584-598

2018

Volltextzugriff (PDF)

Clinical effectiveness of bevacizumab in patients with recurrent brain tumours: A population-based evaluation

Journal of Oncology Pharmacy Practice, 2018-01, Vol.24 (1), p.33-36

2018

Volltextzugriff (PDF)

Challenges of dispensing costly tablets with short shelf-life

Journal of oncology pharmacy practice, 2019-01, Vol.25 (1), p.210-213

2019

Volltextzugriff (PDF)

Rationalizing the use of auxiliary label for oral oncology drugs

Journal of oncology pharmacy practice, 2017-07, Vol.23 (5), p.338-343

2017

Volltextzugriff (PDF)

Evidence-based practice in times of drug shortage

Journal of oncology pharmacy practice, 2016-06, Vol.22 (3), p.566-570

2016

Volltextzugriff (PDF)

Adherence with capecitabine: A population-based analysis based on prescription refill data

Journal of oncology pharmacy practice, 2017-06, Vol.23 (4), p.284-287

2017

Volltextzugriff (PDF)

Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies

Gynecologic oncology, 2006-12, Vol.103 (3), p.1063-1069

2006

Volltextzugriff (PDF)

Pharmacist prescribing

Canadian Medical Association journal (CMAJ), 2008-01, Vol.178 (1), p.65-65

de Lemos, Mário L

2008

Volltextzugriff (PDF)

Comment: evaluation of the modified diet in renal disease equation for calculation of carboplatin dose

The Annals of pharmacotherapy, 2009-11, Vol.43 (11), p.1914-1915

2009

Volltextzugriff (PDF)

Communicating with patients about chemotherapy costs

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2142; author reply 2142-2142

de Lemos, Mário L

2007

Volltextzugriff (PDF)

International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions

Journal of oncology pharmacy practice, 2023-07, Vol.29 (5), p.1065-1074

2023

Volltextzugriff (PDF)

Evaluation of creatinine-based formulas in dosing adjustment of cancer drugs other than carboplatin

Journal of oncology pharmacy practice, 2010-06, Vol.16 (2), p.113-119

2010

Volltextzugriff (PDF)

Potential underdosing of carboplatin in gynecological malignancies

Gynecologic oncology, 2006-09, Vol.102 (3), p.599-599

2006

Volltextzugriff (PDF)

Acute reactions to chemotherapy agents

Journal of oncology pharmacy practice, 2006-09, Vol.12 (3), p.127-129

de Lemos, Mário L

2006

Volltextzugriff (PDF)

Concomitant use of capecitabine and proton pump inhibitors – Is it safe?

Journal of oncology pharmacy practice, 2019-10, Vol.25 (7), p.1705-1711

2019

Volltextzugriff (PDF)

Using expired supply in times of drug shortage

Journal of oncology pharmacy practice, 2012-06, Vol.18 (2), p.319-319

2012

Volltextzugriff (PDF)

Limited role of cockcroft-gault formula in dosing information on product labels for antineoplastic drugs

Canadian journal of hospital pharmacy, 2013-07, Vol.66 (4), p.256-256

2013

Volltextzugriff (PDF)

1 – 25 von 370

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(288)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis

Defining cytotoxic drugs – you know it when you see it?

Efficacy of nivolumab four-weekly dosing schedule based on body weight

Approach to initiating QT-prolonging oncology drugs in the ambulatory setting

Clinical considerations of hyaluronidase as an adjunct to subcutaneous rituximab injection

Loperamide and cardiac events: Is high-dose use still safe for chemotherapy-induced diarrhea?

Safe handling of monoclonal antibodies: Too large to be hazardous?

Survival outcomes associated with different sunitinib dosing regimens in metastatic renal cell carcinoma

A deliberative framework to identify the need for real-life evidence building of new cancer drugs after interim funding decision

Clinical effectiveness of bevacizumab in patients with recurrent brain tumours: A population-based evaluation

Challenges of dispensing costly tablets with short shelf-life

Rationalizing the use of auxiliary label for oral oncology drugs

Evidence-based practice in times of drug shortage

Adherence with capecitabine: A population-based analysis based on prescription refill data

Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies

Pharmacist prescribing

Comment: evaluation of the modified diet in renal disease equation for calculation of carboplatin dose

Communicating with patients about chemotherapy costs

International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions

Evaluation of creatinine-based formulas in dosing adjustment of cancer drugs other than carboplatin

Potential underdosing of carboplatin in gynecological malignancies

Acute reactions to chemotherapy agents

Concomitant use of capecitabine and proton pump inhibitors – Is it safe?

Using expired supply in times of drug shortage

Limited role of cockcroft-gault formula in dosing information on product labels for antineoplastic drugs

Suchergebnisse filtern